Search - tctmd.com

Displaying 1 - 20 of 142

Sort: Relevancy | Date

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

News Daily News

Donor Hearts Fare Better With Novel Method After Circulatory Death

Michael O'Riordan

May 01, 2025

News Daily News

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

Caitlin E. Cox

March 21, 2025

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Daily News

ACC Offers ‘Practical Document’ for Myocarditis Diagnosis and Care

Todd Neale

December 11, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Caitlin E. Cox

September 16, 2024

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Daily News

Long-term Digoxin Use Linked to VT/VF Risk in HF Patients

L.A. McKeown

June 11, 2024

News Daily News

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Yael L. Maxwell

May 08, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

Wearable-Tracked Walking Behavior Hints at Subclinical HF

Caitlin E. Cox

April 23, 2024

Advertisement

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

Donor Hearts Fare Better With Novel Method After Circulatory Death

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Top Heart Failure News of 2024

ACC Offers ‘Practical Document’ for Myocarditis Diagnosis and Care

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Semaglutide Has Similar Benefits in Women and Men With HFpEF

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Long-term Digoxin Use Linked to VT/VF Risk in HF Patients

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Wearable-Tracked Walking Behavior Hints at Subclinical HF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content